We are live on
!
Find out more
SRC
Stone Run Capital Portfolio holdings
AUM
$254M
1-Year Est. Return
12.86%
This Fund
S&P 500
This Quarter
Est. Return
+2.08%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$292M
AUM Growth
+$8.08M
(+2.9%)
Cap. Flow
+$4.46M
Cap. Flow
% of AUM
1.53%
Top 10 Holdings %
Top 10 Hldgs %
38.02%
Holding
64
New
–
Increased
31
Reduced
15
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$2.12M |
| 2 |
Clarivate
CLVT
|
+$1.14M |
| 3 |
Linde
LIN
|
+$813K |
| 4 |
Dentsply Sirona
XRAY
|
+$778K |
| 5 |
Lennox International
LII
|
+$709K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$1.61M |
| 2 |
Teleflex
TFX
|
+$1.43M |
| 3 |
Becton Dickinson
BDX
|
+$1.42M |
| 4 |
Walt Disney
DIS
|
+$1.16M |
| 5 |
Rollins
ROL
|
+$600K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.91% |
| 2 | Healthcare | 28.21% |
| 3 | Industrials | 14.5% |
| 4 | Materials | 14.42% |
| 5 | Communication Services | 4.69% |
Similar funds
TCB
OIA
SSW
JSP
WS
MTWM
KSWA
GA
Stone Run Capital's Q3 2021 Portfolio in Review
As of Q3 2021, Stone Run Capital held 64 positions worth $292M, up 2.9% from $283M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 0%. Stone Run Capital opened no new positions and made no exits, leaving the 64-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.
- Stone Run Capital added most to Fiserv Inc in Q3 2021, an estimated $2.12M increase.
- Stone Run Capital's biggest Q3 2021 reduction was Bio-Techne, cutting an estimated $1.61M.
- Stone Run Capital's ten largest holdings make up 38% of its $292M portfolio in Q3 2021.
- Stone Run Capital opened 0 new positions and closed 0 in Q3 2021.
- Stone Run Capital's portfolio value rose 2.9% quarter-over-quarter to $292M.
Based on Stone Run Capital's 13F filing for Q3 2021, filed 15 Nov 2021.